Research programme: nitric oxide donors - Inotek Pharmaceuticals

Drug Profile

Research programme: nitric oxide donors - Inotek Pharmaceuticals

Alternative Names: Nitric oxide-releasing compounds - Inotek Pharmaceuticals

Latest Information Update: 08 Aug 2007

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Inotek Pharmaceuticals
  • Class
  • Mechanism of Action Nitric oxide donors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Diabetic foot ulcer; Female sexual dysfunction

Most Recent Events

  • 08 Aug 2007 Discontinued - Preclinical for Diabetic foot ulcer in USA (Topical)
  • 08 Aug 2007 Discontinued - Preclinical for Female sexual dysfunction in USA (unspecified route)
  • 10 Nov 2003 Preclinical trials in Diabetic foot ulcer in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top